Literature DB >> 2218497

"Pure" human hematopoietic progenitors: permissive action of basic fibroblast growth factor.

M Gabbianelli1, M Sargiacomo, E Pelosi, U Testa, G Isacchi, C Peschle.   

Abstract

Methodology has been developed that enables virtually complete purification and abundant recovery of early hematopoietic progenitors from normal human adult peripheral blood. A fraction of the pure progenitors is multipotent (generates mixed colonies) and exhibits self-renewal capacity (gives rise to blast cell colonies). This methodology provides a fundamental tool for basic and clinical studies on hematopoiesis. Optimal in vitro cloning of virtually pure progenitors requires not only the stimulatory effect of interleukin-3, granulocyte-macrophage colony-stimulating factor, and erythropoietin, but also the permissive action of basic fibroblast growth factor. These findings suggest a regulatory role for this growth factor in early hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2218497     DOI: 10.1126/science.2218497

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

1.  Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors.

Authors:  N M Sposi; L I Zon; A Carè; M Valtieri; U Testa; M Gabbianelli; G Mariani; L Bottero; C Mather; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 2.  Prospects for homologous recombination in human gene therapy.

Authors:  M A Vega
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

3.  Inhibition of hematopoiesis by competitive binding of transcription factor PU.1.

Authors:  M T Voso; T C Burn; G Wulf; B Lim; G Leone; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 4.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

5.  Ectopic expression of interferon regulatory factor-1 potentiates granulocytic differentiation.

Authors:  E M Coccia; E Stellacci; M Valtieri; B Masella; T Feccia; G Marziali; J Hiscott; U Testa; C Peschle; A Battistini
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

6.  The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.

Authors:  U Testa; F Grignani; P Samoggia; C Zanetti; R Riccioni; F Lo Coco; D Diverio; N Felli; C G Passerini; M Grell; P G Pelicci; C Peschle
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

7.  HoxA10 Terminates Emergency Granulopoiesis by Increasing Expression of Triad1.

Authors:  Hao Wang; Ling Bei; Chirag A Shah; Liping Hu; Elizabeth A Eklund
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

8.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

9.  Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF).

Authors:  M Kan; G C Yan; J Xu; M Nakahara; J Hou
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

10.  Interferon regulatory factor-2 drives megakaryocytic differentiation.

Authors:  Emilia Stellacci; Ugo Testa; Eleonora Petrucci; Eleonora Benedetti; Roberto Orsatti; Tiziana Feccia; Marit Stafsnes; Eliana M Coccia; Giovanna Marziali; Angela Battistini
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.